SUMMARY Important cardiac manifestations in the idiopathic hypereosinophilic syndrome include mitral regurgitation and peripheral embolization. To determine the anatomic basis of these abnormalities, real-time, wide-angle, two-dimensional echocardiography (2-D echo) was performed in 21 patients with the hypereosinophilic syndrome. Nine patients (43%) had clinical evidence of mitral regurgitation, and each had localized thickening of the posterobasal left ventricular wall behind the posterior mitral leaflet and absent (seven patients) or diminished (two patients) motion of the posterior leaflet. Anatomic observations at operation or necropsy in four patients with mitral regurgitation demonstrated that the echocardiographic abnormalities resulted from posterior mitral leaflet thickening and adherence of the leaflet to the underlying mural endocardium of the posterobasal wall. On 2-D echo, each of the six patients with peripheral emboli had either apical left ventricular echo-dense targets consistent with thrombus or thickening of the posterobasal wall of the left ventricle, and these findings were validated at autopsy or operation in three patients.
CARDIAC INVOLVEMENT is a major cause of death in the idiopathic hypereosinophilic syndrome, a systemic illness characterized by a persistently elevated blood eosinophil count without an identifiable etiology for the eosinophilia. l 2 Although almost any organ may be affected, cardiovascular abnormalities have been identified in most patients. 3 Roberts et al. 4 suggested that intracavitary thrombi and extensive endocardial fibrosis are causally related to the occurrence of restrictive cardiomyopathy, atrioventricular valve abnormalities (particularly mitral regurgitation) and peripheral embolism. To determine the morphologic cause of the mitral regurgitation and peripheral embolization, wide-angle two-dimensional echocardiography (2-D echo) was performed in 21 patients with the hypereosinophilic syndrome, and the findings were compared with other clinical features.
Methods

Patients
Twenty-one consecutive patients with the idiopathic hypereosinophilic syndrome who had been identified prospectively at the National Institutes of Health constitute the study group (table 1). All patients had been admitted to the clinical center and extensively evaluated to exclude other causes of peripheral blood eosinophilia. The details of this diagnostic evaluation have been described. 5 The criteria for diagnosis of the idiopathic hypereosinophilic syndrome included a persistent, total eosinophil count of more than 1500 cells/mm3; an extensive evaluation that excluded other known causes of hypereosinophilia, such as parasitic infection, allergy or neoplasm; and clinical or biopsy evidence of organ system involvement. All patients except 1, 3, 6, 7, 9 and 16 (table 1) were being treated with prednisone or hydroxyurea or both at the time of the echocardiographic recording.
Clinical Evaluation
The diagnosis of mitral regurgitation was based on the identification of an apical holosystolic murmur that responded appropriately to bedside physiologic maneuvers. The murmur decreased in intensity with the Valsalva maneuver and with the administration of amyl nitrate, and increased in intensity with squatting. In patients 5. 8 and 10, left ventriculography confirmed the presence of marked mitral regurgitation; each patient subsequently underwent mitral valve replacement. A history of transient ischemic attacks (three patients), or cerebrovascular accident (three patients) was considered evidence of previous peripheral embolism.
Echocardiographic Evaluation
Two-dimensional echocardiograms were obtained with a commercially available, real-time, phased-ar- MR  PE  density PML motion  wall  1  16  M  83,000  11  Skin  0  0  0  0  0  2  21  F  11,000  2  Heart  0  0  0  0  0  3  23  M  7,600  1  GI  0  0  0  0  0  4  27  M ray, 800 ultrasonic sector scanner (V3000 or 3400) using a hand-held 2.25-MHz transducer. Echocardiograms were recorded on either one-half-inch cassette videotape, 1-inch reel-to-reel videotape, or a rhodiumplated chromium disc for subsequent review in realtime, slow-motion or stop-action mode. Single-frame photographs were made from the television monitor using a 35-mm camera.
Two-dimensional echocardiographic examination included the imaging of a number of cross-sectional planes through the heart.68 Serial short-axis views of the left ventricle were obtained by orienting the sector plane perpendicular to the long axis of the left ventricle from a standard transducer placement on the chest. The short-axis sweep was performed by maintaining the transducer in a fixed location on the chest wall and slowly angling the image plane from aorta (cephalad) to apex (caudad). Care was taken to assure proper transducer angulation so that the left ventricle appeared circular rather than oval or elliptical.
The long-axis view was obtained by orienting the sector plan parallel to the longitudinal axis of the left ventricle, taking care to avoid improper angulation of the scan plane tangentially through the ventricle. The apical four-chamber view was obtained with the transducer placed at the cardiac apex and the tomographic plane directed perpendicular to the ventricular and atrial septa and through the plane of the mitral and tricuspid valve orifices to permit simultaneous display of both atria and ventricles, atrioventricular valves and cardiac septa.
Two-dimensional echocardiograms were reviewed independently by two of the authors, one of whom was unaware of the clinical findings. Increased posterobasal wall thickness was identified in the parastemal long-axis view as an abrupt displacement of the endocardial contour at the level of the posterior mitral leaflet, so that the posterobasal region was substantially thicker than was the ventricular free wall distal to the mitral leaflets. This "thickening" of the posterobasal wall was considered to represent either recent thrombus formation, organizing thrombus, or scarring superimposed on the posterobasal left ventricular wall (which itself was of normal or slightly increased thickness).4' 9, 10 Echocardiograms were interpreted as showing absent or markedly limited posterior mitral leaflet motion if no leaflet motion, or only a barely perceptible sug- gestion of motion, was evident in all three echocardiographic image planes. Left ventricular thrombus was considered present if an echo density with distinct margins was present within the ventricular cavity in continuity with the endocardium, but unassociated with the papillary muscles. 11 13 
Pathologic Studies
Material for pathologic examinations was available in four patients. In three, the mitral valve had been excised at operation'4 2-4 weeks after the echocardiographic study; one patient was studied at necropsy 6 months after the echocardiographic studies. Discussion The echocardiographic findings demonstrate a probable mechanism for mitral regurgitation in patients with idiopathic hypereosinophilic syndrome. The patients with mitral regurgitation had thickened posterobasal left ventricular walls and impaired or absent posterior mitral leaflet motion. Morphologic observations at operation or necropsy in four patients with mitral regurgitation showed that the posterobasal left ventricular wall thickening, identified by 2-D echo, was due to the accumulation of thrombofibrotic material between the ventricular aspect of the posterior mitral leaflet and the mural endocardium of left ventricular free wall behind this leaflet and this material in the submitral angle adhered these two structures together.
Our findings regarding the mechanism of mitral regurgitation in hypereosinophilic syndrome support the observations of Davies9 and Brockington and Olsen. 10 Davies,9 in a necropsy study of patients with this disease, reported thickening of the posterior mitral leaflet and noted that the leaflet in some patients adhered to organized, fibrotic thrombus on the surface of the posterior left ventricular wall. Brockington and Olsen'0 reported three patients with this disease in whom the posterior mitral leaflet was incorporated within the fibrotic tissue.
We hypothesize that turbulence of blood flow in the left ventricular inflow tract and apex make these sites on the endocardial surface of the left ventricular wall particularly susceptible to eosinophilic injury and subsequent thrombus formation. Thereafter, clot organization, scarring and new thrombus formation occurs.
Eventually, the posterior mitral leaflet motion is impaired or abolished as the leaflet becomes adherent to, and ultimately incorporated in, the scar and thrombus. The extension of thrombus to adjacent endocardial surfaces followed by thrombus organization and subsequent scarring may result in a restrictive-type ventricle.
Two-dimensional echocardiography was of value in identifying left ventricular thrombi in our patients and also was a sensitive method of identifying patients with hypereosinophilic syndrome who were at risk for peripheral embolization. The rapidity with which this process may evolve in patients with hypereosinophilic syndrome is illustrated by patient 13, who had a cerebral embolus and severe mitral regurgitation at a time when he had 2-D echo evidence of left ventricular apical and inflow tract thrombus, with fixation of the posterior mitral leaflet on 2-D echo ( fig. 6 ). Just 3 months previously, echocardiographic studies had failed to demonstrate thrombus in the left ventricle and the posterior mitral leaflet was normal.
Thus, marked limitation of posterior mitral leaflet motion by adherence to and eventual incorporation within thrombus and scar on the posterobasal endocardial surface of the left ventricle inflow tract is the mechanism by which mitral regurgitation occurs in patients with the hypereosinophilic syndrome. Posterobasal wall thickening and apical left ventricular echo densities suggest the presence of intraventricular thrombi, which are the source of systemic emboli and the cause of the subsequent development of a restrictive ventricle. These findings ( fig. 8) detected by 2-D echo, which is, therefore, a useful adjunct in the cardiac evaluation of patients with the hypereosinophilic syndrome.
